CD274 and neoplasm: This includes base substitutions, copy number alterations, rearrangements, gene fusions, insertions, deletions, and genomic signatures such as the tumor mutational burden (TMB) status, microsatellite instability (MSI), and programmed cell death protein ligand-1 (PD-L1), consolidating these findings into a single assay and report.